A recent in-vivo study done by the UERM Memorial Medical Center Research team shows Difflam-C®, a locally-available antiseptic gargle solution, significantly alleviates the so-called COVID-19 Sore Throat – the most common symptom and tell-tale sign of people diagnosed with COVID-19. The in-vivo study focused on establishing whether the combination of Benzydamine HCl and Chlorhexidine gluconate in Difflam-C® are effective in a real-world setting and was conducted on 219 COVID-19 patients from November 2021 until February 2022. This combination of active ingredients found in Difflam-C® solution have been gaining popularity in the Philippines particularly among doctors and healthcare professionals, with the synergistic action of its anti-inflammatory, analgesic, anesthetic, and antiseptic properties in relieving sore throat, as well as other symptoms of throat and mouth infection. Clinically-tested Efficacy in COVID-19 Patients Lead investigators of the study have found that Difflam-C®
Food & Parenting + Lifestyle